-
2022-501688-42-00
5
2023-05-24
Low Grade Glioma
-
2024-513669-38-00
5
2023-05-17
Stroke, Ischemic, TIA, Cardiac Disease, Atherosclerosis, Myocardial In
-
2023-503481-23-00
5
2023-03-20
Maintenance treatment in metastatic non-squamous lung cancer
-
2024-513754-29-00
5
2023-03-06
Cystic Fibrosis
-
2023-504885-50-00
5
2022-11-07
Treatment of children with chronic kidney disease and proteinuria
-
2023-508425-28-00
4
2022-10-24
Chronic Inflammatory Demyelinating Polyneuropathy
-
2024-510950-29-00
5
2022-07-21
Stereotypical prolonged seizure
-
2024-513857-55-00
4
2022-02-08
Achondroplasia
-
2023-504166-37-00
4
2022-02-01
Advanced ovarian, tubal or peritoneal cancer.
-
2023-504152-97-00
5
2021-11-26
Generalized Myasthenia Gravis
-
2024-511246-39-00
1
2021-07-27
Solid tumours with HER2 aberrations
-
2023-503435-17-00
5
2021-03-31
Juvenile psoriatic arthritis
-
2023-505187-11-00
7
2021-03-01
Duchenne Muscular Dystrophy
-
2024-511868-83-00
5
2021-02-05
Antisynthetase syndrome-related interstitial lung disease
-
2024-516461-36-00
5
2021-01-27
Pregnancy associated hypertension, Pre-Eclampsia, Fetal growth restric
-
2024-511620-13-00
4
2020-06-05
Patient presenting with:
- ectopic ossification secondary to iPPSD2 or
-
2024-512528-13-00
1
2020-05-27
Multiple System Atrophy
-
2023-507883-38-00
5
2019-11-18
Systemic Juvenile Idiopathic Arthritis
-
2023-506131-15-00
5
2019-09-10
Juvenile Idiopathic Arthritis
-
2024-514156-33-00
5
2019-08-20
Patients in remission for granulomatosis with polyangiitis (GPA,
Wegen
-
2024-511862-35-00
4
2019-07-19
Adults with non-contrast-enhancing diffuse brainstem gliomas with non-
-
2024-514094-22-00
5
2019-01-18
Intrecerebral Haemorrhage
-
2024-512701-11-00
4
2018-08-29
Systemic Juvenile Idiopathic Arthritis (sJIA)
-
2023-506027-29-00
5
2014-10-01
Children, adolescents and adults with newly diagnosed diffuse intrinsi